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Abstract
The nonsense mediated decay (NMD) pathway degrades mRNAs bearing premature translation termination codons. In
mammals, SMG-8 has been implicated in the NMD pathway, in part by its association with SMG-1 kinase. Here we use four
independent assays to show that C. elegans smg-8 is not required to degrade nonsense-containing mRNAs. We examine the
genetic requirement for smg-8 to destabilize the endogenous, natural NMD targets produced by alternative splicing of rpl-
7a and rpl-12. We test smg-8 for degradation of the endogenous, NMD target generated by unc-54(r293), which lacks a
normal polyadenylation site. We probe the effect of smg-8 on the exogenous NMD target produced by myo-3::GFP, which
carries a long 39 untranslated region that destabilizes mRNAs. None of these known NMD targets is influenced by smg-8
mutations. In addition, smg-8 animals lack classical Smg mutant phenotypes such as a reduced brood size or abnormal
vulva. We conclude that smg-8 is unlikely to encode a component critical for NMD.
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Introduction
The nonsense mediated decay (NMD) pathway is an evolution-
arily conserved mRNA surveillance mechanism that recognizes
and degrades transcripts bearing premature translation termina-
tion codons [1,2]. In C. elegans, mRNAs that have acquired a
nonsense mutation or an extended 39 untranslated region (UTR)
are targeted for NMD [3]. In addition, physiological transcripts
that carry an early stop codon are substrates for NMD [4,5,6]. The
central players of the NMD pathway were discovered in S. cerevisiae
[7] and C. elegans [1,3,8,9] and comprise SMG-2/Upf1, SMG-3/
Upf2 and SMG-4/Upf3. In worms, Drosophila and mammals, the
NMD core components are modulated by additional SMG factors.
Recent screens have also identified and confirmed new candidate
NMD proteins in C. elegans, H. sapiens and D. rerio [10,11,12].
Elegant studies in several organisms have suggested a model in
which NMD reflects a competition between SMG-2/UPF1 and
Poly(A) Binding Protein (PABP) for ribosome-associated transla-
tion release factors. In mammals, the locations of mRNA splice
junctions are marked by exon-junction complexes (EJC) during
mRNA processing [1]. If the ribosome encounters a premature
termination codon (PTC) during the pioneer round of translation,
the SURF complex, (consisting of SMG-1, UPF1 and the release
factors eRF1 and eRF3) interacts with the EJC, triggers UPF1
phosphorylation by SMG-1 and initiates NMD [13]. In C. elegans,
EJC components are dispensable for NMD, and PTCs are instead
distinguished from normal stop codons by the size of the 39UTR
[10,14]. Once the PTC has been recognized, target mRNAs are
destroyed by either the SMG-6 endonuclease (mammals, Drosophila
and probably worms) [15,16], and/or a SMG-5/SMG-7-depen-
dent exonuclease (mammals, yeast and probably worms) [17,18].
Recently, Yamashita and colleagues used immunoprecipation of
HeLa cell lysates to identify proteins that interact with SMG-1, a
phosphatidylinositol kinase-related protein kinase [19,20]. SMG-1
bound two novel, conserved proteins, FLJ23205 and FJL12886,
which were renamed SMG-8 and SMG-9 [21]. This pair bound
strongly to each other, and modified SMG-1 kinase activity in vitro.
Inactivation of SMG-8 and SMG-9 lead to a partial stabilization
of ß-globin mRNAs in mammalian cell culture, suggesting they
might play a role in NMD. The authors also used RNA
interference (RNAi) to inactivate C. elegans smg-8 and smg-9, and
concluded that smg-8, but not smg-9, contributed to NMD in
worms [21].
Here we examine C. elegans smg-8 using a newly generated
mutant allele. smg-8(tm2937) contains a 272 bp deletion and a
1 bp insertion within smg-8 (Figure 1A). This deletion encompasses
22 bp upstream of the start site, the initiator ATG and the first two
exons. Using animals homozygous for this allele, we employed four
approaches to investigate a possible role for smg-8 in the NMD
pathway. Our findings suggest that smg-8 is unlikely to be a key
component for NMD in C. elegans.
Results and Discussion
smg-8 Mutants do not Exhibit Phenotypes Associated
with NMD Mutants
For our first assay, we examined two of the classical phenotypes
associated with smg genes. Hodgkin and colleagues reported a
reduced brood size of 174 (range 147–211) for smg-1, which was
lower than the mean brood size of wild-type animals (327, range
270–373) [9]. We observed a mean brood size of 301 (range 242–
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wild-type strain (279, range 211–328, n=10) (Table 1). In
addition, animals bearing a mutation in a canonical smg gene
have a protruding vulva due to morphological defects [9].
However, vulvae appeared normal in smg-8(tm2937) worms
(Figure 1B). These data suggest that smg-8(tm2937) animals lack
two overt phenotypes associated with canonical smg mutants.
smg-8 does not Show an NMD Phenotype for the Native
NMD Target rpl-7a and rpl-12
For our second assay, we examined transcripts for two
ribosomal proteins rpl-7a and rpl-12, which are natural NMD
targets [4]. These genes each generate two alternatively spliced
mRNAs, one of which contains a premature termination codon
(PTC; Figure 2A). When NMD is active, the longer isoform
containing the PTC is degraded and only the shorter isoform
accumulates. When the NMD pathway is compromised, the
isoform containing the PTC is stabilized, and both mRNA
isoforms accumulate (Figure 2A). Using RT-PCR primers that
flank the PTC, it is possible to distinguish between the two
transcripts [4]. smg-8 shows no NMD phenotype by this assay.
When a known component of the NMD pathway, such as smg-1,
smg-2 or smg-3, is mutated, the mRNA isoform containing the PTC
is stabilized, generating a robust upper band (Figure 2B). In
contrast, for smg-8(tm2937), a very faint upper band was observed,
comparable to that of the wild-type strain (Figure 2B). To extend
this result, we inactivated smg-8 and also smg-9 using RNAi, which
reduced smg mRNA levels at least five-fold (Figure 2G) and similar
to a No Reverse Transcriptase negative control (Figure 2H). The
results were again negative for NMD (Figure 2C). RNAi is not
always robust; therefore we repeated the assay using the strain eri-
6/7(tm1917), which enhances RNAi [22,23], and once more
observed no NMD phenotype (Figure 2D). Finally, to exclude the
possibility that the tm2937 allele was hypomorphic, we treated smg-
8(tm2937) mutants with smg-8 RNAi or smg-9 RNAi, but again we
observed no NMD phenotype (Figure 2E). Similar results were
observed for rpl-12 (Figure 3).
To quantify these data, we used RT-qPCR to measure the
increase of the PTC containing isoform. We observed a fold
enrichment of 15 and 38 in smg-1 and smg-3 mutants respectively,
compared to the wild-type (Figure 2F). The PTC containing
isoform in smg-8 mutants remained similar to the wild-type (0.7
fold enrichment). A virtually identical result was obtained with
smg-8 RNAi treatment of smg-8 or eri-6/7 mutant worms (0.7 and
0.4 fold enrichment respectively) (Figure 2F). Together, these data
reveal that inactivation of smg-8 fails to stabilize two natural NMD
targets, rpl-7a and rpl-12.
Figure 1. smg-8 lacks the vulva phenotype associated with mutations in other NMD genes. (A) Schematic representation of the tm2937
allele, which contains a 272 bp deletion and a 1 bp insertion. This deletion encompasses 22 bp upstream of the start site and the first two exons.
Arrows indicate primers used for RT-qPCR (B) Vulval protrusion is one of the phenotypes of canonical smg genes. Left panel shows a wildtype vulva,
middle panel shows a smg-8(tm2937) mutant and right panel shows a smg-1(r861) mutant. smg-8 mutants are similar to wild-type and not to smg-1.
Arrowheads denote the vulva.
doi:10.1371/journal.pone.0049490.g001
Table 1. Brood Size Comparison of smg-1 and smg-8 vs wild-
type.





Average progeny (n=10 mothers) at 20uC. Progeny were counted every day
until no more progeny were observed.
*Data from [9].
doi:10.1371/journal.pone.0049490.t001
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PLOS ONE | www.plosone.org 2 November 2012 | Volume 7 | Issue 11 | e49490Figure 2. smg-8 lacks an NMD phenotype for the native NMD target rpl-7a. (A) Schematic representation of the two alternatively spliced
isoforms of rpl-7a. The isoform containing the premature termination codon (PTC) is subject to degradation by NMD, whereas the shorter isoform is
not. RT-PCR was performed using a pair of primers that distinguish the two spliced isoforms (purple arrows). (B) The upper, PTC band is visible only
when the NMD pathway is compromised by smg-1, smg-2 or smg-3 mutations (lanes 2, 3 and 4). Only the lower WT band is observed in wild-type
(lane 1) and smg-8 mutant (lane 5) animals. (C) Wild-type worms were fed bacteria expressing dsRNA targeting smg-1, smg-8 or smg-9 from the
Ahringer dsRNA library [26]. RNA was analyzed as in (B). (D) An enhanced RNAi mutant strain eri-6/7 [22,23] was used and RNAi conducted as in (C).
RNA was analyzed as in (B). (E) As in D, using the smg-8(tm2937) mutant strain. (F) RT-qPCR using primers flanking the PTC-containing isoform of rpl-
7a, mRNA levels were calculated using the delta-delta-CT method, relative to the control gene pmp-3 [27]. Fold enrichment of the PTC mRNA was
normalized to 1 for wild-type. The smg-1 and smg-3 mutants show an enrichment of 15 and 38 fold, respectively. In contrast, in smg-8 mutants, the
accumulation of the PTC containing isoform is similar to wild-type (0.7 fold enrichment). smg-8 and eri-6/7 mutant worms treated with smg-8 RNAi
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As a third test for NMD, we examined an endogenous target of
the NMD pathway: unc-54(r293) [3,9]. The unc-54 gene generates
a muscle myosin heavy chain (MHC) in C. elegans, and the unc-
54(r293) allele contains a 256 bp deletion that removes the normal
39 cleavage/polyadenylation site and most of the 39UTR [3]
(Figure 4A). This deletion causes the production of a long unc-54
mRNA transcript that terminates at a cryptic poly(A) site and
renders unc-54 an NMD target. Without the MHC, unc-54 mutant
worms are paralyzed (Figure 4B). In the absence of NMD
components such as smg-1, the unc-54(r293) mRNA is stabilized,
wild-type protein is produced and the Unc phenotype is
suppressed [3] (Figure 4B). We generated unc-54(r293); smg-
8(tm2937) double mutants and observed no suppression of the
paralysis phenotype (Figure 4B), consistent with our hypothesis
that smg-8 is not required for NMD in C. elegans.
smg-8 does not Restore Expression the Exogenous NMD
Target myo-3::GFP
As a fourth test for NMD, we examined an exogenous NMD
target, myo-3::GFP. This strain carries a transgenic GFP reporter
that is transcribed in body wall muscles and targeted for
degradation by a long 39UTR (Figure 5A) [24]. When the
NMD pathway is inactive, GFP accumulates in muscle fibers,
whereas wild-type worms accumulate almost no GFP (Figure 5B).
We created double combinations of myo-3::GFP and smg-1, smg-3 or
smg-8. The strain myo-3::GFP; smg-8(tm2937) accumulated very
little GFP compared to the positive controls myo-3::GFP; smg-
1(r861) or myo-3::GFP; smg-3(r867) (Figure 5B), indicating that smg-
8 is not required for exogenous NMD in C. elegans.
In summary, we tested smg-8 for a role in NMD using four
different assays: i) anatomical phenotype and brood size, ii)
accumulation of natural NMD targets rpl-7a and rpl-12, iii) rescue
of the paralysis phenotype caused by the endogenous NMD target
unc-54(r293) and iv) GFP accumulation of the exogenous NMD
target reporter myo-3::GFP. The discrepancy between our study
and the results presented by Yamashita and colleagues is due in
part to the use of an allele (our study) vs. RNAi [21]. In addition,
we note that the effect of smg-8 inactivation on NMD in C. elegans
was not robust in the Yamashita study [21]. In all of our assays,
smg-8 mutants resembled wild-type worms and differed from
classical smg mutants. We detected no accumulation of mRNA or
protein in smg-8 mutants, even when the smg-8 mutation was
combined with RNAi. We suggest that smg-8 in C. elegans is a novel,
conserved gene whose function remains to be elucidated.
Materials and Methods
Strains
Worm growth and maintenance were performed as described
before [25]. Strains used: SM1618 unc-54(r293)I, SM456 smg-
1(r861)I, SM436 smg-2(e2008)I, SM196 smg-3(r867)IV, smg-
1(r861);unc-54(r293)I, smg-8(tm2937)II;unc-54(r293)I, CL724
dvIs38 [pCL60 (Pmyo-3::GFP::degron/long 39 UTR)+pRF4],
SM1944 smg-1(r861)I;myo-3::GFP, SM1929 smg-3(r867)IV;myo-
3::GFP, SM1937 smg-8(tm2937)II;myo-3::GFP, SM1881 smg-
8(tm2937)II eight times outcrossed.
RNA Interference
HT115 bacteria expressing double stranded RNA targeting smg-
1, smg-8 or smg-9 grown for ,8 hours at 37uC were plated using
1 mM IPTG (Sigma) and 50 mg/ml of Carbenicillin (Sigma).
RNAi clones were derived from the Ahringer library [26] and
verified by sequencing. Five wild-type, smg-8(tm2937) or eri-6/
7(tm1917) worms were transferred at the L4 stage to RNAi plates
and allowed to lay embryos for one day. The progeny was
collected ,48 hours later, when most worms had grown at least to
the L4 stage, by rinsing with water and frozen at -80uC for
show 0.7 and 0.4 fold enrichment, respectively. (G) RT-qPCR to quantify smg-8 RNA. mRNA levels were calculated using the delta-delta-CT method,
relative to the control gene pmp-3 [27]. Fold enrichment was normalized to 1 for wild-type. smg-8 and eri-6/7 worms treated with smg-8 RNAi show
0.3 and 0.26 fold enrichment, respectively. (H) As in (G) for wild-type animals and a negative control that lacked Reverse Transcriptase (No RT). Fold
enrichment was normalized to 1 for wild-type. No RT control shows 0.3 fold enrichment.
doi:10.1371/journal.pone.0049490.g002
Figure 3. smg-8 lacks an NMD phenotype for the native NMD target rpl-12. (A) RT-PCR was performed using a pair of primers that distinguish
the two spliced isoforms of rpl-12; the upper, PTC band is visible only when the NMD pathway is compromised by smg-1, smg-2 or smg-3 mutations
(lanes 2, 3 and 4). Only the lower, WT band is observed in wild-type (lane 1) and smg-8 mutant (lane 5) animals. (B) Wild-type worms were fed bacteria
expressing dsRNA targeting smg-1, smg-8 or smg-9 from the Ahringer dsRNA library [26]. RNA was analyzed as in (A). (C) As in (B), using an enhanced
RNAi mutant eri-6/7 [22,23]. (D) As in (B), using the smg-8(tm2937) mutant strain.
doi:10.1371/journal.pone.0049490.g003
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strain per experiment.
RNA Extraction
For total RNA extraction, glass beads (Sigma) and 1 ml of
Trizol Reagent (GibcoBRL) were added to frozen worm pellets.
Pellets were lysed by vortex followed by chloroform extraction.
RNA was precipitated with isopropanol and washed with 70%
ethanol. Resuspended RNA was extracted with phenol:chloroform
and precipitated with ethanol. A first-strand reaction kit (NEB) was
used to perform the reverse transcriptase reaction, following the
manufacturers protocol.
RT-PCR of rpl
Amplification of rpl-7a from the cDNA was performed as
described in [4], and PCR product was analyzed in a 1% agarose
gel. Primers used were rpl-7a-fw GACATCCAGCCAAA-
GAAGGA and rpl-7a-rv AACGGTGTTTGGTCTCTTGG.
Primers for rpl-12 are Rpl-12-F1 ACCCAAGACTG-
GAAGGGTCT and Rpl-12 R1 GCCATCGATCTTGGTCT-
CAT.
RT-qPCR
For smg-8 and rpl-7a, mRNA levels were calculated using the
delta-delta-CT method, relative to the control gene pmp-3 [27].
Control mRNA was normalized to 1 and the mRNA levels are
shown as relative fold change. Primers for smg-8 were smg8-fw-
4348 GCTGCCAATATTTCCATCGT and smg8-rv-5165
TGACCACGGGAACATTCATA.
Brood Size
10 worms at the L4 stage were picked into individual plates at
20uC. Their progeny was counted everyday until no more progeny
was generated. The number of progeny per plate was averaged
(n=10).
Figure 4. smg-8 is not required for endogenous NMD in C. elegans. (A) unc-54 gene schematic. The r293 allele contains a 256 bp deletion
within unc-54 that includes the 39 cleavage and polyadenylation site. (B) smg-8(tm2937) or smg-1(r861) mutations were combined with unc-54(r293).
Two worms were placed in the middle of the bacterial lawn and allowed to crawl for 45 minutes. Wild-type worms that crawl (top left) leave tracks in
the lawn whereas unc-54(r293) mutants cannot move well (top right). smg-1(r861) suppresses unc-54(r293) mRNA degradation and restores
movement [3] (bottom left). In contrast, smg-8 does not suppress the paralysis phenotype (bottom right). Arrowheads indicate the tracks left by
paralyzed worms.
doi:10.1371/journal.pone.0049490.g004
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